Search

everythinglearnresearchcommunity

for

Search:↓

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Plum blossom acupuncture and electroacupuncture improved hair growth and quality of life in a woman with chronic hair loss.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

HIV patients with lower CD4 T cell counts often have more skin problems.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Skin stem cells help create protective immune cells during wound healing.

Autoimmune reactions may cause both alopecia areata and HAM.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Alopecia Areata might be linked to Crohn's disease.